#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16352	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2149	757.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1428	1428	C	947	C	884	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16352	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2149	757.0	0	HET	.	.	.	C1450T	.	1450	1450	C	1694	1694	C	932	C,T	688,186	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30034	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	820.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1708	1708	A	937	A,G	881,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30034	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	820.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2342	2342	C	952	C,A,T	877,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30034	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	820.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2416	2416	A	1018	A	954	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30034	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	820.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2968	2968	C	911	C	848	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30034	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3649	820.9	0	HET	.	.	.	T695C	.	695	695	T	1066	1066	T	966	T,C	486,406	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	10	blaTEM	861	266	99.62	blaTEM.l15.c30.ctg.1	311	1.6	0	.	p	.	0	A211V	NONSYN	631	633	GCG	36	38	GTG	1;1;1	G;T;G	1;1;1	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2314	folP	855	855	100.0	folP.l6.c30.ctg.1	1471	156.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1034	1036	AGC	229;225;229	A;G;C	216;216;219	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5142	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3439	149.3	1	SNP	p	S91F	1	.	.	271	273	TTC	605	607	TTC	177;178;178	T;T;C	166;166;163	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5142	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3439	149.3	1	SNP	p	G95N	0	.	.	283	285	GGC	617	619	GGC	177;174;176	G;G;C	165;163;167	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5142	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3439	149.3	1	SNP	p	D95G	1	.	.	283	285	GGC	617	619	GGC	177;174;176	G;G;C	165;163;167	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1796	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1327	135.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	952	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1021	92.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	186.6	1	SNP	p	D86N	0	.	.	256	258	GAC	518	520	GAC	232;233;231	G;A;C	218;217;218	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	186.6	1	SNP	p	S87R	1	.	.	259	261	CGT	521	523	CGT	230;231;229	C;G,A;T	220;218,1;214	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	186.6	1	SNP	p	R87I	0	.	.	259	261	CGT	521	523	CGT	230;231;229	C;G,A;T	220;218,1;214	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	186.6	1	SNP	p	R87W	0	.	.	259	261	CGT	521	523	CGT	230;231;229	C;G,A;T	220;218,1;214	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	186.6	1	SNP	p	S88P	0	.	.	262	264	TCC	524	526	TCC	230;229;225	T;C;C	217;217;214	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4758	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2671	177.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1565	1567	GGC	209;201;204	G;G;C	192;188;188	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1312	1314	GCA	222;225;226	G,A;C;A	198,1;201;208	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1315	1317	ATC	229;230;229	A;T,C;C	212;210,1;211	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1327	1329	GTG	226;227;225	G;T;G	206;209;203	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1327	1329	GTG	226;227;225	G;T;G	206;209;203	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1831	1833	ACC	237;237;238	A;C;C	212;216;218	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1885	1887	GCG	215;214;215	G;C;G	187;177;182	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1885	1887	GCG	215;214;215	G;C;G	187;177;182	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2008	2010	AGC	179;177;178	A;G;C	167;166;168	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2017	2019	GGC	184;182;182	G;G;C	167;165;163	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4338	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2387	180.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2035	2037	CCG	156;163;163	C,G;C,G;G	122,6;130,1;131	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6262	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3125	199.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1664	1666	CCG	203;202;203	C;C;G	182;184;180	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2606	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1828	142.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	536	536	C	180	C	170	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	58	60	TTA	50;52;52	T;T;A	37;40;40	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	103	105	CAT	59;58;57	C;A;T	58;57;56	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	106	108	AGT	58;58;58	A;G;T	57;57;57	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	115	117	TAC	58;58;59	T;A;C	57;57;57	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	R307E	NONSYN	919	921	AGA	205	207	GAA	17;16;17	G;A;A	17;16;17	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	217	219	GCA	20;20;20	G;C;A	19;20;20	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	226	228	ATC	20;20;20	A;T;C	19;18;19	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	232	234	TCG	20;19;19	T;C;G	17;18;17	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	238	240	GCC	20;21;21	G;C;C	19;21;19	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	241	243	AGC	21;21;21	A;G;C	18;19;20	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	244	246	GCC	22;23;22	G;C;C	18;21;19	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	270	92.22	porB1a.l15.c30.ctg.2	394	29.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	250	252	GTT	22;23;22	G;T;T	18;23;19	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3046	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1451	207.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	890	890	T	268	T	253	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3046	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1451	207.2	1	SNP	p	G120K	0	.	.	358	360	GGT	617	619	GGT	238;233;234	G,T;G;T	222,1;219;217	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3046	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1451	207.2	1	SNP	p	A121D	0	.	.	361	363	GCC	620	622	GCC	234;232;233	G;C,T;C	218;218,1;221	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3046	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1451	207.2	1	SNP	p	A121N	0	.	.	361	363	GCC	620	622	GCC	234;232;233	G;C,T;C	218;218,1;221	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11430	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4828	236.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1200	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1051	113.6	1	SNP	p	V57M	1	.	.	169	171	ATG	542	544	ATG	236;234;234	A,G;T;G	225,1;223;224	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
